Inicio>>Signaling Pathways>> Membrane Transporter/Ion Channel>> nAChR>>Ispronicline

Ispronicline

Catalog No.GC63548

La isproniclina (TC-1734), un agonista parcial del receptor de nicotina acetilcolina α4β2 selectivo del cerebro (nAChR), activo por vÍa oral, ha mostrado propiedades de mejora de la memoria en roedores y un buen perfil de tolerabilidad.

Products are for research use only. Not for human use. We do not sell to patients.

Ispronicline Chemical Structure

Cas No.: 252870-53-4

Tamaño Precio Disponibilidad Cantidad
5 mg
81,00 $
Disponible
10 mg
135,00 $
Disponible
25 mg
288,00 $
Disponible
50 mg
477,00 $
Disponible
100 mg
765,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Ispronicline (TC-1734), an orally active, brain-selective α4β2 nicotine acetylcholine receptor (nAChR) partial agonist, has shown memory-enhancing properties in rodents and a good tolerability profile. Ispronicline binds to the α4β2 nAChR with high affinity (Ki=11 nM) and is highly selective to other nAChRs such as α7 nAChR and α3β4 nAChR[1][2].

Ispronicline (10-20 mg/kg; s.c.) induces c-Fos expression in selective regions of the rat forebrain[1]. Ispronicline pharmacokinetics (half-life of 2 h in rats) contrasts with the long-lasting improvement of working memory (18 h to 2 d)[2].

[1]. Julie Jacobsen, et al. The α4β2 nicotine acetylcholine receptor agonist ispronicline induces c-Fos expression in selective regions of the rat forebrain. Neurosci Lett. 2012 Apr 25;515(1):7-11.

Reseñas

Review for Ispronicline

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ispronicline

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.